Cogent Biosciences (COGT) PEG Ratio
Market Cap: $528.26M
Avg Volume: 1.38M
Industry: Biotechnology
Sector: Healthcare
PEG Ratio Summary
- Cogent Biosciences's trailing twelve month (TTM) PEG ratio is -2.48.
- Cogent Biosciences's annual PEG ratio as of today is -0.05.
- Cogent Biosciences's quarterly PEG ratio is 0.68.
What is the PEG Ratio?
The PEG ratio (Price/Earnings to Growth ratio) is a valuation metric for determining the relative trade-off between the price of a stock, the earnings generated per share (EPS), and the company's expected growth. A lower PEG ratio suggests that a stock may be undervalued given its earnings performance and growth potential.
How is the PEG Ratio calculated?
The PEG ratio is calculated by dividing the P/E ratio by the annual EPS growth. The formula is:
PEG Ratio = (P/E Ratio) / (EPS Growth Rate)
This helps investors to determine a stock's value while considering the company's earnings growth.
Related Metrics
Other important metrics to assess Cogent Biosciences's financial health include:
- P/E Ratio (Price to Earnings Ratio) - measures the company's current share price relative to its per-share earnings:
- Annual: -2.24
- Quarterly: -3.17
- TTM: -2.00
- P/S Ratio (Price to Sales Ratio) - compares the company's stock price to its revenues:
- Annual: 0.00
- Quarterly: 0.00
- TTM: 0.00
- P/B Ratio (Price to Book Ratio) - compares the company's market value to its book value:
- Annual: 2.23
- Quarterly: 3.36
- TTM: 2.00
- P/CF Ratio (Price to Cash Flow Ratio) - compares the company's market value to its cash flow:
- Annual: -2.75
- Quarterly: -14.22
- TTM: -2.47
These metrics provide insights into Cogent Biosciences's financial health and its ability to meet short-term obligations. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
TTM PEG Ratio
-2.48
Annual PEG Ratio
-0.05
Quarterly PEG Ratio
0.68
Cogent Biosciences Historical PEG Ratio
Historical P/E Ratio
Historical P/S Ratio
Historical P/B Ratio
Historical P/CF Ratio
Cogent Biosciences Historical Financial Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | PEG Ratio | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|---|
| 2024 | -0.05 | -2.24 | 0.00 | 2.23 | -2.75 |
| 2023 | -0.34 | -2.43 | 0.00 | 1.82 | -3.05 |
| 2022 | -0.23 | -5.12 | 0.00 | 2.66 | -5.72 |
| 2021 | 0.07 | -4.63 | 0.00 | 1.55 | -5.66 |
| 2020 | -0.04 | -1.87 | 15.81 | 0.53 | -3.47 |
| 2019 | 0.03 | -0.72 | 0.98 | 0.69 | -0.53 |
| 2018 | -0.05 | -3.17 | 11.25 | 1.82 | -3.37 |
| 2017 | -1.14 | -12.89 | 39.32 | 11.61 | -12.72 |
| 2016 | -0.08 | -14.36 | 40.95 | 4.97 | -13.96 |
| 2015 | 0.00 | -39.47 | 87.14 | 3.74 | 14.69 |
Related Metrics
Explore detailed financial metrics and analysis for COGT.